Triglycerides, CDC, Serum
Use
Measurement of triglycerides as part of lipoprotein profiling. Increased plasma triglyceride levels are indicative of a metabolic abnormality and, along with elevated cholesterol, are considered a risk factor for atherosclerotic disease. Hyperlipidemia may be inherited or associated with conditions such as biliary obstruction, diabetes mellitus, nephrotic syndrome, kidney failure, or metabolic disorders related to endocrinopathies. Elevated triglycerides may also be linked to alcohol consumption, sedentarism, or medication use, such as prednisone.
Special Instructions
Not provided.
Limitations
Triglyceride results can be falsely decreased in patients with elevated levels of certain substances like N-acetyl-p-benzoquinone imine (a metabolite of acetaminophen), N-acetylcysteine, and metamizole. Accurate fasting (12 hours) and abstaining from alcohol (24 hours before collection) are necessary for reliable results.
FDA ApprovedNew York Approved
Methodology
Automated Analyzer (Clinical Chemistry)
Biomarkers
Triglycerides
Analyte
LOINC Codes
- 2571-8 - Trigl SerPl-mCnc
- 2571-8 - Trigl SerPl-mCnc
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
5 mL
Minimum Volume
0.25 mL
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Patient Preparation
Fasting: 12 hours, required. Patient must not consume any alcohol for 24 hours before specimen collection.
Causes for Rejection
Gross hemolysis
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | 60 days |